HSBC Holdings’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

HSBC Holdings’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,984	Closed	-$855K	–	2894
2019 Q1	$855K	Sell	4,984 -8,436	-63%	-$1.26M	﹤0.01%	1894
2018 Q4	$1.93M	Sell	13,420 -770	-5%	-$172K	﹤0.01%	1508
2018 Q3	$4.53M	Sell	14,190 -9	-0.1%	-$2.84K	0.01%	1167
2018 Q2	$5M	Buy	+14,199	New	+$4.4M	0.01%	1130

Other funds holding ASLN

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

HSBC Holdings's ASLN Position: Q2 2019 in Review

HSBC Holdings sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q2 2019, closing a stake of 4,984 shares — an estimated $855K sold.

HSBC Holdings first reported a position in ASLN in Q2 2018 and held it in 4 quarters. The position peaked at $5M in Q2 2018. 7 funds tracked by Wall St. Rank hold ASLN as of Q2 2019.

HSBC Holdings reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q2 2019 after selling out during the quarter.
HSBC Holdings sold 4,984 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q2 2019, an estimated $855K.
HSBC Holdings first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q2 2018 and held it in 4 quarters.
HSBC Holdings's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $5M in Q2 2018.
7 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q2 2019.

Based on HSBC Holdings's 13F filing for Q2 2019, filed 13 Aug 2019.